NCT07494565
- Conditions
- CD5 Positive, Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
CD5 Positive
Explore clinical trials studying CD5 Positive. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
CD5 Positive trial results
Active, Not Recruiting
Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT03946878
- Conditions
- Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States